Select your language

Other official information and services: www.belgium.be  belgium

  • Key figures
  • Data
  • Graphics
  • Comments
PRESCRIBERS
Main prescribers: General practitioners 85.94%
RATE OF USE
Annual consumption (DDD) 567,047,374
Standardised rate of use (per 100,000 insured persons) 4,945,823.54
Average annual consumption per patient (DDD) 379.71
% Insured persons concerned 13.03%
Approximate % DDD issued outside the insurance 6.49%
% Patients with more than 3 times the average consumption 4.06%
POPULATION
Median age 69 years
Max/min ratio of the median age (by district) 1.04
Percentage of women 43.31%
Ratio Preferential scheme/General scheme 1.25
CONSUMPTION TRENDS (DDD)
Trend 2011-2021 1.60%
Trend 2011-2019 1.58%
Trend 2019-2021 1.68%
GEOGRAPHICAL VARIATIONS
Coefficient of variation 2011-2013 10.15
Coefficient of variation 2019-2021 16.48
Max/min ratio of consumption (DDD per 100,000 insured persons, by region) 1.49
Max/min ratio of consumption ( DDD per 100,000 insured persons, by district) 1.75
DIRECT EXPENDITURE
Annual expenditure charged to the insurance 70,239,413
Average annual expenditure per insured person 6.13
Average patient share (under insurance) 23.80%
Max/min ratio of expenditure per insured person (by region) 1.43
Max/min ratio of expenditure per insured person (by disctrict) 1.65
% “Low-cost” medication 91.19%


On this table, when a statistical test has been performed, the data showing a significant difference is displayed on an yellow background, otherwise on a grey background.

CODES LABEL LABEL ATC-5
C10AA01 SIMVASTATINE INHIBITEURS DE LA HMG-CoA REDUCTASE (STATINES)
C10AA03 PRAVASTATINE INHIBITEURS DE LA HMG-CoA REDUCTASE (STATINES)
C10AA04 FLUVASTATINE INHIBITEURS DE LA HMG-CoA REDUCTASE (STATINES)
C10AA05 ATORVASTATINE INHIBITEURS DE LA HMG-CoA REDUCTASE (STATINES)
C10AA07 ROSUVASTATINE INHIBITEURS DE LA HMG-CoA REDUCTASE (STATINES)

The labels on a blue background are the medicines that exist under the status "low cost".
The codes mentioned above can be used in rates and expenses, or only in expenses. We invite you to consult the full report for more information.

Click here to see the graph illustrating the evolution of the breakdown by volume of ATC codes used for the rates.

No selection

2021

  • ATC codesATC codes
  • Age Gender CVAge, gender and CV
  • Rates by sexRates by sex
  • Reimbursement rateReimbursement rate
  • TrendsTrends by region
  • Trends breakTrends break
  • Dot PlotDot Plot
  • Funnel PlotFunnel plot
  • Provincial consumptionDDD per patient by province
  • DDD patientQuantity per patient
  • MapDistribution map
  • Low-costLow-cost DDD


WE ARE INTERESTED IN YOUR OPINION

Do you have any experience in this area ? We listen to you !

Send us an email

Download the full report
Download the methodology